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In humans, the hypothalamic neuropeptide oxytocin shifts the individual’s focus on self-
interest toward group-serving cognitions and decision-making. Here we examine this
general tendency in the context of group formation, where individuals included into their
group (or not) 18 targets morphed as having low or high-threat potential (with high-threat tar-
gets being beneficial to group-interests but potentially hurting the recruiter’s self-interest).
Ninety healthy males self-administered oxytocin or placebo in a randomized double-blind,
placebo-controlled study design, had their hands scanned to derive fetal testosterone vs.
estradiol exposure from their 2D:4D ratio, and self-reported on their chronic empathic con-
cern. Multilevel regression models revealed that when given oxytocin rather than placebo,
individuals with low fetal testosterone priming included low-threat targets more and high-
threat targets (somewhat) less. Individuals with high fetal testosterone (i.e., low estradiol)
exposure, however, included high-threat targets more, and low-threat targets less when
given oxytocin rather than placebo. Second, when given oxytocin rather than placebo, indi-
viduals with low empathic concern included low-threat targets more and high-threat targets
less. Individuals with high empathic concern, however, included high-threat targets more,
and low-threat targets less when given oxytocin rather than placebo.We conclude that oxy-
tocin shifts the individual’s focus from self to group-serving cognition and decision-making,
and that these tendencies are stronger for males with high rather than low fetal testos-
terone vs. estradiol exposure, and high rather than low empathic concern. Implications and
avenues for future research are discussed.
Keywords: oxytocin, testosterone, threat, empathy, social decisions
INTRODUCTION
Throughout evolution, humans have moved in and out of groups,
relaxing and tightening their interdependencies with others, and
selecting and rejecting others into more or less closely knit social
units that function well and provide their individual members
with protection and survival opportunities (Kameda et al., 2005;
Bowles and Gintis, 2012). Whereas the behavioral sciences identi-
fied a host of social and personality factors underlying human
socialization, bonding, and group formation and maintenance
(e.g., Baumeister and Leary, 1995; Rusbult and Van Lange, 2003;
Mikulincer and Shaver, 2010; Ellemers, 2012), these issues received
scant attention in the biological and neurosciences. However,
because bonding, socializing, and forming groups provides strong
survival benefits to the individual (Darwin, 1859), such group
formation tendencies may rest on evolved neurohormonal cir-
cuitries (De Dreu, 2012a). Here we examine this possibility,
and study whether and how (i) possible effects of the hypo-
thalamic neuropeptide oxytocin on group formation are mod-
erated by (ii) the ratio of fetal testosterone vs. estradiol expo-
sure as revealed by variation in the relative length of the second
(index) to fourth finger (2D:4D ratio; Manning et al., 2002), and
(iii) chronic empathic concern (Davis, 1983; Frith and Singer,
2008).
OXYTOCIN MOTIVATES GROUP-SERVING COGNITION AND
DECISION-MAKING
In forming and expanding one’s group, humans may select group-
members based on characteristics such as the other’s attractiveness,
friendliness, trustworthiness, or social status. Especially in a com-
petitive setting, humans face the dilemma between including
strong, domineering others that strengthen the group and pro-
vide protection against outside threat vs. engaging submissive
and trustworthy others that may promote rather than threaten
the recruiter’s personal interest. Searching for, and selecting
strong others with high-threat potential serves group-interests
more than personal interests, whereas inviting submissive oth-
ers with low-threat potential serves personal interests more than
group-interests (Kurzban et al., 2001; Benenson et al., 2009).
As such, coalescing with strong, domineering others may be
seen as part of the general inclination to serve group rather
than immediate self-interest, and this in turn may be driven by
the same neurobiological circuitries as other forms of group-
serving behaviors such as parochial altruism, social attachment,
and parental care (Madden and Clutton-Brock, 2011; De Dreu,
2012a).
Among the possible neural circuitries underlying group-
serving cognition and behavior, the oxytonergic circuitry clearly
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stands out as most promising. Oxytocin is an evolutionary ancient,
nine-amino-acid neuropeptide produced in the hypothalamus.
Functioning as hormone and neurotransmitter, it targets the
amygdala, hippocampus, and regions of the spinal cord that
regulate the parasympathetic branch of the autonomic nervous
system (Ludwig and Leng, 2006; Neumann, 2008; Rodrigues
and Sapolsky, 2009). Oxytocin interacts with the hypothalamic-
pituitary-adrenal axis to attenuate stress responses, and this
has a pervasive influence throughout both the body and the
brain (Neumann, 2008; Heinrichs et al., 2009; Bos et al., 2012).
For example, oxytocin reduces cortisol levels after exposure to
stressors, inhibits cardiovascular stress responses, and modu-
lates brain areas and neural circuitries involved in processing
fear-related information (Kirsch et al., 2005; Baumgartner et al.,
2008; for reviews see Heinrichs et al., 2009; Bos et al., 2012).
Furthermore, at least in non-human mammals, oxytocin inter-
acts with reward processing circuitries like the inferior frontal
gyrus, the caudate nucleus, and the nucleus accumbens (Skuse
et al., 2005; Ludwig and Leng, 2006; Donaldson and Young,
2008).
Oxytocin has well-established roles in reproduction and pair-
bond formation (Carter et al., 2008; Donaldson and Young, 2008;
Kavaliers and Choleris, 2011). In humans, it promotes social
approach, trust, and cooperation (Kosfeld et al., 2005; Baum-
gartner et al., 2008; De Dreu et al., 2011), especially when inter-
action partners belong to one’s own group (De Dreu et al.,
2010). Thus, individuals given oxytocin rather than placebo con-
form to the preferences of their own group but not to those of
out-groups (Stallen et al., 2012), display more positive attitudes
toward fellow group-members (De Dreu et al., 2011), cooper-
ate more within their group (De Dreu et al., 2010; Israel et al.,
2012), and display greater competition toward (out-group) rivals
that threaten the members of one’s group (Shamay-Tsoory et al.,
2009; De Dreu et al., 2010; Hahn-Holbrook et al., 2011; De Dreu,
2012a).
These and related studies together reveal that oxytocin plays
a critical role in shifting the individual’s focus on immedi-
ate personal interest, toward a broader focus on (long-term)
group-interest (De Dreu, 2012a). For group formation and new-
comer selection, this implies that oxytocin motivates a prefer-
ence for allies with high-threat potential more than for allies
with low-threat potential (who serve the recruiter’s immedi-
ate self-interests more). Indeed, Evans et al. (2010) showed
that intranasal administration of oxytocin reduced aversion of
angry faces, and De Dreu (2012b) showed that, in the context
of inter-group competition, individuals who inhaled oxytocin
rather than placebo were more likely to select allies that had
high rather than low-threat potential (i.e., were high on domi-
nance and low on trustworthiness; Oosterhof and Todorov, 2008).
Furthermore, under oxytocin rather than placebo, high-threat
targets were perceived as more useful allies, and their assess-
ment of usefulness accounted for the decision to include targets
with high rather than low-threat potential. From this, it appears
that at least under oxytocin, the motivation to include high-
threat members is driven by the desire to protect and promote
the group, more than by reduced fear of being hurt in one’s
self-interests.
OXYTOCIN’S EFFECTS DEPEND ON FETAL TESTOSTERONE EXPOSURE
Neurohormones such as oxytocin influence the nervous system at
a functional level by changing the activity of a given neural cir-
cuitry, or at the structural level by changing the architecture and/or
connectivity of different nodes of the neural circuit. Compared
to the usually rapid and short-lived functional effects on neural
excitability and neurotransmission, structural effects are slow and
long-lasting and can include the recruitment and/or removal of
new cells to the circuit (neurogenesis vs. apoptosis), or changes
in the connectivity of the circuit (synaptic plasticity; Soares et al.,
2010; Peper and Koolschijn, 2012). Structural effects come about
after long-term exposure to specific triggers of hormone release,
such as continued drug usage or exposure to high stress environ-
ments (Lederbogen et al., 2011), because of hormone exposure at
critical phases in pre- and post-natal brain development, or some
combination.
Here we conjecture that structural changes due to fetal testos-
terone vs. estradiol priming moderate acute effects of oxytocin.
A brain which is shaped by prenatal exposure to high levels of
estradiol or testosterone may be differentially receptive to oxy-
tocin administration in adult life. Testosterone is a sex steroid
hormone functioning as an oxytocin antagonist (Carter et al.,
1988; Carter, 2003), and fetal testosterone exposure produces reli-
able structural effects on the brain and on behavior in adult life
(Lombardo et al., 2012, also see Beach et al., 1982; Clark et al., 1988;
Wayner et al., 1988). There is also evidence that estradiol produced
during prenatal life influences brain structure and adult behavior
(Hutchison, 1997; Bakker et al., 2006; Bakker and Baum, 2008). In
both humans and non-human primates, a reliable biomarker of
the ratio of fetal testosterone vs. estradiol exposure is the length
of the second (index) finger relative to the ring finger (2D:4D),
with lower 2D:4D reflecting higher fetal testosterone relative to
estradiol exposure (Brown et al., 2002; Manning, 2002)1.
In humans, higher fetal testosterone exposure (a low 2D:4D)
has been associated with risk tolerance (Coates and Herbert, 2008;
Campbell et al., 2010), sensation seeking (Fink et al., 2006), cooper-
ation (Millet and Dewitte, 2006), and success in team sports (Man-
ning and Taylor, 2001, for a review see Knickmeyer et al., 2011), all
characteristics of social dominance (Eisenegger et al., 2011). From
these and related findings it appears that rather than driving self-
interested cognition and decision-making, high fetal testosterone
exposure associates with more pro-active, goal-oriented behavior,
and therefore, higher fetal testosterone exposure may be associ-
ated both with more self-interested decision-making or with more
group-serving decision-making (also see van Honk et al., 2011,
2012). Whether the focus is on self-interest or group-interests then
depends on external factors that determine the relative salience of
group-relative to self-interest. Because the availability of brain oxy-
tocin enables a shift in focus from self-interests to group-interests,
acute effects of oxytocin will be moderated by fetal testosterone
exposure. Applied to group formation and ally selection, we should
then find that individuals with high fetal testosterone exposure
prefer group-members that have high-threat potential more when
1Digit ratio reflects fetal testosterone relative to estradiol exposure, with lower digit
ratios reflecting higher testosterone/lower estradiol exposure (Lutchmaya et al.,
2004). For readability, we heretofore refer to testosterone exposure.
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they received oxytocin rather than placebo (Hypothesis 1A); and
group-members that have low-threat potential less when they
received oxytocin rather than placebo (Hypothesis 1B).
OXYTOCIN’S EFFECTS DEPEND ON CHRONIC EMPATHIC CONCERN
In forming groups and alliances, people may not only be driven by
instrumental concerns regarding their self- or group’s interests, but
also by more or less chronic tendencies to empathize with others
(Batson, 1998; Frith and Singer, 2008). Individuals with chronic
empathic concern may be more likely to affiliate and bond with
others, and experience other’s imagined pain and negative emo-
tional states more vividly, than those with lower levels of empathic
concern (Davis, 1983; Singer et al., 2004). Compared to individuals
with low empathic concern, those with high empathy may thus be
more likely to include rather than exclude others into their group
(Davis, 1996). Furthermore, individuals with high empathic con-
cern may be more likely to focus on group-interests and forego or
even sacrifice immediate self-interests – those with empathic con-
cern may thus be more likely than individuals with low empathic
concern to include others with high-threat potential and, perhaps,
less likely to include others with low-threat potential.
These lines of evidence on empathic concern, combined with
our conjecture that oxytocin shifts the focus from self-interest to
group-interest, imply that acute effects of oxytocin on group for-
mation and ally selection are contingent upon chronic individual
differences in empathic concern. Accordingly, we predicted that
especially individuals with high empathic concern prefer group-
members with high-threat potential more when they receive
oxytocin rather than placebo (Hypothesis 2A); and prefer group-
members with low-threat potential less when they receive oxytocin
rather than placebo (Hypothesis 2B).
SUMMARY AND OVERVIEW OF THE CURRENT STUDY
Male subjects filled out a short questionnaire to assess their
chronic empathic concern, had their right-hand scanned to infer
fetal testosterone exposure from their 2D:4D ratio, and self-
administered oxytocin or placebo (double-blind, randomized
between-subjects design). Subjects were shown a series of targets,
with facial features being morphed into neutral, low-threat, or
high-threat, and for each target, subjects indicated whether they
would include the target into their group. We tested predictions
regarding inclusion decisions (Hypotheses 1A–2B), and explored
possible effects on ratings of choice certainty, target’s perceived
usefulness, and target’s perceived dangerousness.
MATERIALS AND METHODS
PARTICIPANTS
Ninety males (mean age= 21.49, SD= 2.78, range 18–29) partic-
ipated for C10 (approximately 13 USD). Exclusion criteria were
medical or psychiatric illness, medication, smoking, and drug or
alcohol abuse. The study was performed in accordance with the
Declaration of Helsinki and approved by the Ethics Committee of
the University of Amsterdam. All participants provided informed
consent prior to the study. The data of four participants were
dropped prior to hypothesis testing because they had extremely
fast reaction times paired with odd response patterns such as
always pressing the same button or in turn responding with “yes”
and “no”). We conjectured they did not take the task seriously.
MATERIALS
As targets for selection we used six different actors’ faces, that were
morphed into low-threat, high-threat (as in De Dreu et al., 2012),
or neutral (Oosterhof and Todorov, 2008; www.facegen.com),
yielding a total of 18 targets. Although people rely on a multi-
tude of cues when perceiving and interpreting faces, Oosterhof
and Todorov (2008) identified trustworthiness and dominance as
the two orthogonal dimensions that are sufficient to describe face
evaluation. While face-trustworthiness is more sensitive to features
signaling whether the person should be avoided or approached,
dominance evaluation is more sensitive to features signaling phys-
ical strength/weakness. Threatening faces should be both untrust-
worthy (signaling that the person may have harmful intentions)
and dominant (signaling that the person is capable of causing
harm). Although these computer faces are somewhat artificial,
the advantage is that other features of the face (e.g., symmetry)
can be kept constant, thus creating optimal conditions for a clean
hypothesis test (Oosterhof and Todorov, 2008; Said et al., 2011).
Furthermore, using the same low and high-threat targets as used in
De Dreu (2012b) enables a near-exact replication of their findings.
INDEPENDENT VARIABLES AND EXPERIMENTAL PROCEDURES
Participants came in-groups of two to six individuals, and were
seated individually in soundproof cubicles. They were randomly
assigned to the oxytocin or placebo group and tested individually.
Participants self-administered, under experimenter supervision, a
single intranasal dose of 24 IU placebo or oxytocin (Syntocinon-
Spray Novartis; three puffs per nostril, with 1 minute in between
puffs). The placebo contained all the active ingredients except for
the neuropeptide, and was manufactured by Stichting Apothekers
Haarlemse Ziekenhuizen in coordination with the pharmacy at
the Amsterdam Medical Center, adhering to the European Union
guidelines on Good Manufacturing Practice and Good Clinical
Practice. Placebos were delivered in the same bottles as Syntocinon.
Following Treatment, the experimenter left the cubicle and
participants filled out the Dutch translation of the seven-item
Empathic Concern scale (Davis, 1983; de Corte, 2007). It measures
the participant’s feelings of warmth, compassion, and concern
for others (always 1= does not describe me well, to 5= describes
me very well; Cronbach’s α= 0.775; M = 3.07, SD= 0.48)2. Here-
after, participants proceeded with a series of unrelated, computer-
guided tests.
Because effects of oxytocin plateau approximately 35 minutes
after administration (Baumgartner et al., 2008), the computer
switched to the instructions for the main task after 30 minutes. Par-
ticipants were engaged in a behavioral game in which they made
a number of choices between cooperation and non-cooperation
(i.e., BG-Prisoner’s Dilemma; De Dreu, 2012b) and then pro-
ceeded to the current task. They read a brief introduction stating
that oftentimes people form groups by selecting others or not,
and that they would be shown a series of pictures of faces, each
time answering whether they would include this person into their
2Participants also completed the Perspective Taking Scale (Davis, 1983; de Corte,
2007; M = 2.97, SD= 0.43; relationship to Empathic Concern, r= 0.29, p< 0.01)
and we explored its effects, alone or in interaction with Treatment and 2D:4D.
Including or excluding Perspective Taking had no effects whatsoever.
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group or not. In total, participants were shown 18 pictures, each
on a new screen and randomized per participant. For each pic-
ture they answered a series of questions (see “dependent variables”
below).
At the end of the experiment, and before debriefing, partici-
pant’s right-hand was scanned to calculate the ratio of the length
of the index finger to the length of the ring finger (2D:4D), as
an indicator of fetal testosterone exposure. We collected partic-
ipants’ hand scans and computed digit lengths from the crease
closest to the finger to the fingertip using photo-editing software
(M = 0.96, SD= 0.03), a method that has been previously vali-
dated by comparing it to bone measurements taken from x-rays
(Manning, 2002).
DEPENDENT VARIABLES
For each target, participants indicated whether they would include
the target in their group (0=NO; 1=YES), and then how certain
they were of their decision, how useful, and how dangerous they
judged the target (always 1= not at all, to 5= very much). The
latter three questions were presented in random order, and the
target’s picture remained visible on the computer screen.
RESULTS
STATISTICAL ANALYSES
Hypotheses were tested using generalized linear mixed models
with a binominal distribution for the (binary) inclusion decisions,
and with linear distributions for the other dependent (contin-
uous) variables. Fixed factors included Treatment (oxytocin vs.
placebo; between-subjects) and Target’s Threat Potential (low vs.
neutral vs. high; within-subjects), as well as their interactions with
(continuous and centered) 2D:4D and Empathic Concern. A ran-
dom intercept was included, as well as a random intercept for each
trial. This allowed each trial to have its own intercept across par-
ticipants, over and beyond the random intercept per participant.
The initial models included all the predictors of interest, and to
create the final model, non-significant fixed factors were deleted
one by one (see Table 1). This statistical approach is advocated in
Garson (2012). Fetal testosterone exposure (2D:4D) did not corre-
late with empathic concern (r =−0.022, p= 0.838, and statistical
conclusion validity appeared not threatened by multicollinearity
(Empathic Concern: Tolerance= 0.903, VIF= 1.107, λ= 1.005,
Condition Index= 1.142; 2D:4D: Tolerance= 0.998, VIF= 1.002,
λ= 0.685, Condition Index= 1.383).
INCLUSION DECISIONS (HYPOTHESES 1A–2B)
Hypotheses on selection decisions were tested in a generalized
mixed model with selection decision (0= no, 1= yes) as binary
dependent variable. Table 1 shows the final model results. We
observed an interaction between 2D:4D ratio and Target’s Threat
Potential, F(2, 1.530)= 6.027, p= 0.002, which was qualified by
the predicted three-way interaction among Treatment, 2D:4D and
Target’s Threat Potential, F(2, 1.530)= 4.064, p= 0.017.
To interpret this complex interaction, the two-way interaction
among Treatment and 2D:4D is plotted separately for Target’s
Threat Potential. For neutral Targets we had no a priori predictions
but observed that neutral targets were included more by individu-
als with low rather than high testosterone exposure, regardless of
Treatment. For high and low-threat Targets, Treatment and 2D:4D
interacted, as predicted in Hypothesis 1A and 1B. When given
oxytocin rather than placebo, individuals with low testosterone
exposure included low-threat targets more. Individuals with high
testosterone exposure, however, included high-threat targets more
(Hypothesis 1A), and low-threat targets less (Hypothesis 1B) when
given oxytocin rather than placebo (see also Figures 1A,B). Put
differently, the pattern of inclusion of low vs. high-threat targets
observed earlier in De Dreu (2012b) is replicated among individu-
als with high testosterone exposure (low 2D:4D ratios), and tends
to reverse among individuals with low testosterone exposure (high
2D:4D ratios).
Hypotheses about the moderating influence of Empathic Con-
cern received support too. Table 1 shows that the higher partici-
pants’ empathic concern the more often they decided to include
Table 1 |Tests of model effects.
Decision Certainty˚ Usefulness˚ Dangerousness˚
F Sig. F Sig. F Sig. F Sig.
Treatment 0.179 0.672 0.988 0.321 0.684 0.409 0.282 0.596
Target’s threat 0.760 0.468 0.829 0.369 0.586 0.450 41.723 0.000
2D:4D 0.010 0.921 3.387 0.067 8.963 0.003
Treatment×2D:4D 0.006 0.939 6.023 0.015 7.234 0.007
Target’s threat×2D:4D 6.027 0.002 3.695 0.055 12.865 0.000
Treatment× target’s threat×2D:4D 4.064 0.017 6.493 0.011 5.795 0.016
Empathic concern 4.597 0.032 6.164 0.013
Treatment× target’s threat 0.357 0.700 1.670 0.197 0.960 0.328 0.365 0.546
Treatment×empathic concern 0.009 0.926 6.655 0.010
Target’s threat×empathic concern 1.904 0.149 7.767 0.005
Treatment× target’s threat×EC concern 8.897 0.000 4.137 0.042
˚Included targets only
Significant factors are printed in bold.
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someone into their team, F(1, 1.533)= 4.597, p= 0.032. This
main effect was qualified by a three-way interaction among
Treatment, Empathic Concern, and Target’s Threat Potential,
F(2, 1.533)= 8.897, p= 0.0001. Again, we plotted the two-way
interaction among Treatment and Empathic Concern separately
for Targets with low, neutral, and high-threat potential. Neu-
tral Targets were included more by individuals with low rather
than high testosterone exposure, regardless of Treatment. For
low and high-threat Targets, Treatment, and Empathic Concern
interacted as predicted in Hypothesis 2A and 2B. When given
oxytocin rather than placebo, individuals with low empathic con-
cern included low-threat targets more and high-threat targets
(somewhat) less. Individuals with high empathic concern, how-
ever, included high-threat targets more, and low-threat targets less
when given oxytocin rather than placebo (see Figures 2A,B). Put
differently, the pattern of inclusion of low vs. high-threat targets
observed earlier in De Dreu et al. (2012) is replicated among indi-
viduals with high empathic concern, and tends to reverse among
individuals with low empathic concern.
EXPLORATORY ANALYSES
Choice certainty
We examined the certainty of inclusion decisions, and observed
a three-way interaction among Treatment, 2D:4D ratios, and Tar-
get’s Threat Potential, F(1, 675.096)= 6.493, p= 0.011 and inter-
actions between 2D:4D ratios and Target’s Threat Potential F(1,
669.372)= 6.695, p= 0.055 and Treatment and 2D:4D ratios F(1,
313.070)= 6.023, p= 0.015. The pattern somewhat mimicked the
FIGURE 1 | Fetal testosterone exposure moderates effects of
oxytocin on inclusion decisions. Low-threat targets [(A) examples in
bottom left panel] are preferred less and high-threat targets [(B)
examples in bottom right panel] are preferred more by individuals with
high fetal testosterone vs. estradiol exposure when given oxytocin
rather than placebo. Fetal testosterone vs. estradiol prenatal priming
ratio was included as a continuous variable in our model. For
visualization purposes, we plotted the interaction with this continuous
variable centered once at +1 SD (dotted lines) and once at −1 SD (solid
lines).
FIGURE 2 | Empathic concern moderates effects of oxytocin on inclusion decisions. Low-threat targets (A) are preferred less and high-threat targets (B)
are preferred more by individuals with high empathic concern when given oxytocin rather than placebo.
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one observed for selection decisions: When given oxytocin rather
than placebo, individuals with low testosterone exposure felt more
certain about included low-threat targets and less certain about
included high-threat targets. Individuals with high testosterone
exposure, however, felt more certain about high-threat targets, and
less certain about low-threat targets when given oxytocin rather
than placebo (see Figures 3A,B).
Target usefulness
For rated usefulness of included targets, we observed a main effect
for Empathic Concern, F(1, 483.862)= 6.164, p= 0.013, two-
way interactions between Treatment and Empathic Concern, F(1,
474.871)= 6.655, p= 0.01 and between Target’s Threat Poten-
tial and Empathic Concern, F(1, 680.300)= 7.767, p= 0.005, and
a three-way interaction among Treatment, Empathic Concern,
and Target’s Threat Potential, F(1, 691.734)= 4.137, p= 0.042.
Figures 4A,B shows the Treatment× Empathic Concern interac-
tions separately for high-threat and low-threat Targets. As can be
seen, usefulness ratings differed as a function of Empathic Con-
cern and Treatment mostly in the low-threat potential condition.
When given oxytocin rather than placebo, individuals with high
empathic concern found the low-threat targets that they included
more useful. Individuals with low empathic concern,however,gave
lower usefulness ratings to low-threat targets when given oxytocin
rather than placebo. Highly empathic participants, regardless of
treatment, rated the by them included high-threat targets as more
useful than low empathic participants.
Target dangerousness
Dangerousness of included targets varied as a function of Target’s
Threat Potential, F(1, 27.382)= 41.723, p< 0.0001, and 2D:4D,
F(1, 362.745)= 8.963, p= 0.003. High-threat Targets were con-
sidered more dangerous than low-threat or neutral Targets, and
individuals with low testosterone exposure perceived included
targets as more dangerous than individuals with high testos-
terone exposure. These effects were qualified by two-way inter-
actions between 2D:4D ratios and Target’s Threat Potential, F(1,
674.359)= 12.865,p= 0.0004, and between Treatment and 2D:4D
ratios, F(1, 360.824)= 7.234, p= 0.007, as well as a three-way
interaction among Treatment, 2D:4D ratios, and Target’s Threat
Potential, F(1, 681.028)= 5.795, p= 0.016.
Figures 5A,B show the interactions among Treatment× 2D:4D
ratios for high-threat and low-threat Targets, respectively. As can
been, those with high levels of prenatal testosterone rated the by
them included low-threat targets as more dangerous and high-
threat targets as less dangerous under oxytocin vs. placebo. A
reverse pattern was observed in those with low levels of prenatal
testosterone: these participants rated the by them included low-
threat targets as less dangerous and high-treat targets as more
dangerous under oxytocin vs. placebo.
FIGURE 3 | Fetal testosterone exposure moderates effects of oxytocin on certainty of inclusion decisions. Certainty about including low-threat targets (A)
is lower and about high-threat targets (B) is higher among individuals with high fetal testosterone exposure when given oxytocin rather than placebo.
FIGURE 4 | Empathic concern moderates effects of oxytocin on
usefulness of included targets. Low-threat targets (A) are perceived as
less useful by individuals with high fetal testosterone exposure when
given oxytocin rather than placebo; High-threat targets (B) are perceived
as more useful by individuals with high empathic concern regardless of
Treatment.
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FIGURE 5 | Fetal testosterone exposure moderates effects of oxytocin on perceived dangerousness of included targets. Low-threat targets (A) are seen
as more dangerous and high-threat targets (B) as less dangerous by individuals with high fetal testosterone exposure when given oxytocin rather than placebo.
DISCUSSION
The nature and outlook of groups are shaped by continuous inclu-
sion and exclusion decisions made by individual group-members.
By including strong individuals with high-threat potential, the
recruiter’s self-interests may be jeopardized yet group-interests are
promoted, as adding strong individuals with high-threat potential
makes the group stronger and provides protection against outside
danger and rivaling out-groups. Here we observed that intranasal
oxytocin (vs. placebo) motivated individuals to include high-
threat targets, and to exclude low-threat targets. Importantly, these
group-serving tendencies induced by oxytocin came about only in
individuals with high fetal testosterone (vs. estradiol) exposure, or
with high chronic empathic concern.
Results support the conjecture that a brain shaped by high
fetal testosterone exposure is differentially responsive to oxytocin
administration than a brain shaped by high fetal estradiol expo-
sure (and low testosterone exposure). Although this being the very
first study showing acute effects of oxytocin are moderated by fetal
testosterone exposure, our findings fit with those on testosterone
administration and fetal testosterone exposure reported by van
Honk et al. (2011), and with the general conclusion that neuro-
hormonal release may have both structural and acute effects that
may operate independently but also interact (Soares et al., 2010;
Peper and Koolschijn, 2012).
We anticipated moderation of acute oxytocin effects by propos-
ing that higher fetal testosterone relative to estradiol exposure
renders individuals more pro-active and goal-oriented, and that
brain oxytocin shifts the focus from immediate self-interest to
group-serving cognition and decision-making. This conjecture
was further supported by exploratory analyses on choice cer-
tainty and perceived dangerousness of included targets aligned
with inclusion decisions – especially individuals with high fetal
testosterone exposure given oxytocin rather than placebo felt more
certain about including high-threat targets, and perceived them as
less dangerous. Together, this suggests that fetal testosterone expo-
sure can be expected to moderate the effects of other variables
known to shift the individual’s focus from self- to group-interest,
such as team rather than individual incentives, third party instruc-
tions to cooperate rather than compete, or facing familiar and
in-group protagonists rather than un-familiar individuals (e.g.,
Baumeister and Leary, 1995; De Dreu et al., 2008).
The finding that acute effects of oxytocin were moderated by
individual differences in empathic concern fits with Bartz et al.
(2011) who concluded that effects of oxytocin on social cogni-
tion and behavior depend on the individual’s chronic predisposi-
tions and personality traits. We proposed that chronic empathic
concern provides a latent tendency to serve the group, which
brain oxytocin turns into more manifest decision-making. This
proposition was further supported by exploratory analyses on per-
ceived usefulness of included targets – especially individuals with
high empathic concern given oxytocin rather than placebo rated
included high-threat targets as more useful.
Empathy is a multidimensional construct that relies on affec-
tive and cognitive component processes (Shamay-Tsoory, 2011).
Our findings pertain to the affective empathy (empathic concern),
but not to cognitive empathy (perspective taking, see text foot-
note 1). Affective and cognitive empathy relate to distinct neural
circuitries. Brain regions activated by cognitive empathy include
medial prefrontal regions, the superior temporal sulcus (STS),
and the temporo-parietal junction (Farrow et al., 2001; Gallagher
and Frith, 2003; Shamay-Tsoory et al., 2003, 2005a,b; Decety and
Jackson, 2004). In contrast, brain regions activated by affective
empathy mostly include somatosensory and insular cortices as
well as limbic areas and the anterior cingulate cortex (Nummen-
maa et al., 2008; Lang et al., 2011; for a review, see Hein and Singer,
2008). Interestingly, brain regions involved in affective empathy
are more easily influenced by oxytocin than brain regions involved
in cognitive empathy (Shamay-Tsoory et al., 2010), and this may
explain why chronic empathic concern did and perspective taking
did not moderate acute effects of oxytocin on group formation
and ally selection.
We included male participants only, and cannot exclude the
possibility that females respond differently to target selection
when given oxytocin rather than placebo. Intranasal oxytocin
sensitizes males to competitive interactions, and females to affil-
iation (Fischer-Shofty et al., 2012), and there is some evidence
that while oxytocin down-regulates fear-responding in males, it
actually boosts fear-responding in females (Lischke et al., 2012).
Especially when it comes to moderation by fetal exposure to sex
hormones, it may be that our findings are limited to males and
new research is needed to address this possibility. Second, our tar-
get selection task did not enable individuals to compose groups.
It stands to reason that well-functioning groups contain mix-
tures of different personality types – overrepresentation of strong,
domineering individuals may be as problematic as overrepresen-
tation of submissive individuals. The current target selection task
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does not inform us about the way groups are composed, and new
research is needed to examine whether oxytocin, alone or in con-
junction with fetal exposure to sex hormones and/or empathic
concern, leads to specific preferences for group compositions.
Third, we propose that those with high levels of testosterone expo-
sure selected high-threat allies because oxytocin made them more
group-focused. Although we cannot rule out that oxytocin made
participants select group-members who are more like them (dom-
inant in appearance), dangerousness ratings suggest this to be
unlikely. Those with low 2D:4Ds under oxytocin rated low-threat
targets as more dangerous, presumably because they would not
be able to strengthen the group and not because they are unlike
themselves.
Brain oxytocin enables individuals to consider group rather
than self-interests (De Dreu,2012a),and this may motivate them to
include strong, domineering newcomers with high-threat poten-
tial (De Dreu, 2012b). Earlier work explicitly positioned group
formation in the context of an inter-group competition. Absent
such explicit reference to inter-group rivalry, we observed here
that ally selection induced by oxytocin administration is highly
contingent upon chronic differences in empathic concern, and
prenatal testosterone vs. estradiol exposure. These findings sug-
gest that especially among individuals set to pro-actively serve
group-interests, oxytocin induced group-serving cognition and
decision-making tendencies that would favor the group as a whole.
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